Insider Selling: Arthur S. Kirsch Sells 2,500 Shares of POZEN Stock (POZN)
POZEN (NASDAQ:POZN) Director Arthur S. Kirsch sold 2,500 shares of POZEN stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $8.73, for a total value of $21,825.00. Following the sale, the director now directly owns 26,000 shares in the company, valued at approximately $226,980. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
A number of analysts have recently weighed in on POZN shares. Analysts at TheStreet upgraded shares of POZEN from a “sell” rating to a “hold” rating in a research note on Monday, May 12th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. POZEN has an average rating of “Hold” and an average target price of $9.92.
Shares of POZEN (NASDAQ:POZN) traded down 3.68% on Tuesday, hitting $8.38. The stock had a trading volume of 254,703 shares. POZEN has a one year low of $4.73 and a one year high of $9.90. The stock has a 50-day moving average of $8.53 and a 200-day moving average of $8.34. The company’s market cap is $258.6 million.
POZEN (NASDAQ:POZN) last announced its earnings results on Thursday, May 8th. The company reported $0.09 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.04) by $0.13. The company had revenue of $7.55 million for the quarter, compared to the consensus estimate of $5.50 million. During the same quarter last year, the company posted ($0.19) earnings per share. POZEN’s revenue was up 433.5% compared to the same quarter last year. On average, analysts predict that POZEN will post $0.58 earnings per share for the current fiscal year.
POZEN Inc (NASDAQ:POZN), is a pharmaceutical company focused on transforming medicine.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.